'Resident Evil 6,' this is not.

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the ...

Edgewise Therapeutics (EWTX) announced that on December 31, 2025, Edgewise granted inducement stock options to purchase a total of 119,250 shares of Edgewise’s common stock to 4 new non-executive ...

WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through ...

BioTouch, a health care logistics company based in West Haven, Connecticut, announced three weeks ago it will invest $12.5 million to expand its two kit manufacturing facilities in Columbus. Now, the ...

In case you've faced some hurdles solving the clue, Shiver-inducing, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, ...

On Sept. 3, the Ledger-Enquirer reported that JS Link America, a U.S.-owned subsidiary of Korean biotechnology company JS Link, will invest $223 million to create a rare-earth permanent magnet ...